GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
4

4DMedical 4DX.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

2.34

+2.63%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2026

Revenue

A$7.1m

FY2017FY2026

Net income

−A$204.4m

FY2017FY2026

Free cash flow

−A$32.2m

FY2017FY2026

Shareholders' equity

A$170.2m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueA$7.1mA$5.9mA$3.8mA$718,581A$1.1mA$216,978A$1.2mA$695,000A$789,259A$1,925
Research and developmentA$144,413A$2.5mA$4.9mA$6.7mA$4.4mA$2.4mA$3.5mA$2.3m——
Operating income−A$57.5m−A$47.5m−A$28.0m−A$30.7m−A$36.8m−A$18.7m−A$16.0m−A$7.0m−A$5.2m−A$4.7m
Net income−A$204.4m−A$30.1m−A$36.0m−A$31.5m−A$24.6m−A$21.4m−A$22.0m−A$6.5m−A$3.9m−A$4.0m
Diluted earnings per share-0.03-0.06-0.06-0.08-0.07-0.07-0.08-0.02-0.03-0.03

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsA$365.3mA$94.8mA$120.0mA$92.9mA$74.3mA$92.6mA$15.8mA$9.0mA$5.5mA$4.9m
Cash and short-term investmentsA$278.0mA$6.9mA$30.6mA$69.6mA$51.1mA$80.9mA$8.4mA$3.1mA$1.7mA$1.2m
Total liabilitiesA$195.2mA$30.6mA$49.1mA$21.5mA$14.8mA$9.3mA$27.6mA$4.5mA$1.7mA$1.7m
DebtA$3.2mA$4.3mA$5.1mA$5.1mA$6.2mA$1.7mA$16.9mA$3.0mA$1.0mA$1
Shareholders' equityA$170.2mA$64.2mA$70.9mA$71.5mA$59.5mA$83.4m−A$11.8mA$4.6mA$3.8mA$3.2m
Shares outstanding6,815m496m618m372m330m294m265m265m148m152m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−A$31.3m−A$34.5m−A$30.9m−A$22.7m−A$25.3m−A$14.5m−A$7.7m−A$5.8m−A$3.4m−A$2.2m
Capital spending−A$949,830−A$85,838−A$302,873−A$731,313−A$3.1m−A$725,003−A$1.2m−A$1.3m−A$1.4m−A$1.1m
Free cash flow−A$32.2m−A$34.6m−A$31.2m−A$23.4m−A$28.3m−A$15.2m−A$8.8m−A$7.1m−A$4.8m−A$3.3m

Latest quarters

By quarter end

Jun 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024
RevenueA$4.2mA$2.9mA$2.9mA$1.5mA$1.5mA$2.9mA$2.9mA$3.0m
Operating income−A$30.9m−A$26.5m−A$26.5m−A$24.0m−A$24.0m−A$12.9m−A$12.9m−A$14.6m
Net income−A$50.3m−A$154.1m−A$154.1m−A$5.5m−A$5.5m−A$19.2m−A$19.2m−A$20.4m
Diluted earnings per share-0.01-0.31-0.31-0.01-0.01-0.03-0.03-0.03
Cash from operations−A$18.0m−A$12.0m−A$12.0m−A$20.0m−A$20.0m−A$14.0m−A$14.0m−A$16.0m
Total assetsA$365.3mA$139.5mA$139.5mA$94.8mA$94.8mA$102.0mA$102.0mA$120.0m
Cash and short-term investmentsA$278.0mA$56.8mA$56.8mA$6.9mA$6.9mA$16.0mA$16.0mA$30.6m
DebtA$1.0mA$1.1mA$10.2mA$1.1mA$5.4mA$1.0mA$5.9mA$944,592
Shareholders' equityA$170.2m−A$28.4m−A$28.4mA$64.2mA$64.2mA$59.9mA$59.9mA$70.9m

Financial ratios

Data as of 29 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Operating margin-813.7%-822.8%-956.8%-5053.0%-3485.8%-8654.3%
Net margin-2895.1%-513.7%-958.3%-4378.0%-2332.6%-9872.2%
Return on equity-120.1%-46.8%-50.7%-44.0%-41.3%-25.7%
Return on assets-56.0%-31.7%-30.0%-33.9%-33.1%-23.1%
Free cash flow yield-0.1%-2.1%-1.5%-1.8%-2.1%-1.4%
Revenue growth20.6%55.9%422.5%-31.8%385.9%-82.4%
Earnings growth579.9%-16.4%14.4%27.9%14.8%-2.5%
Current ratio30.79x0.89x1.78x4.60x6.16x10.51x
Debt to equity0.05x0.02x0.01x0.01x0.02x0.01x
Equity ratio46.6%67.8%59.1%76.9%80.1%90.0%
Interest coverage-21.08x-188.80x-136.09x-123.52x-204.67x-6.98x
R&D as a share of sales2.0%42.8%130.5%932.8%421.5%1086.8%
Buybacks as a share of market value-1274.9%19.8%-66.4%-12.8%-11.9%-11.2%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue114.2%100.7%35.0%
Operating income23.3%25.1%52.3%
Net income86.6%57.0%74.2%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-812.7%-940.8%-1174.1%-1163.3%
Net margin-1815.8%-1736.5%-1864.8%-1772.5%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-80.3-64.8-8.3-8.4-5.6-18.6-29.3
Price to sales—332.879.0369.7131.3——

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.